Alec A. Desai

844 total citations
24 papers, 567 citations indexed

About

Alec A. Desai is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Alec A. Desai has authored 24 papers receiving a total of 567 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Radiology, Nuclear Medicine and Imaging, 16 papers in Molecular Biology and 5 papers in Infectious Diseases. Recurrent topics in Alec A. Desai's work include Monoclonal and Polyclonal Antibodies Research (19 papers), Protein purification and stability (10 papers) and Glycosylation and Glycoproteins Research (6 papers). Alec A. Desai is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (19 papers), Protein purification and stability (10 papers) and Glycosylation and Glycoproteins Research (6 papers). Alec A. Desai collaborates with scholars based in United States, Denmark and India. Alec A. Desai's co-authors include Peter M. Tessier, Lilia A. Rabia, Emily K. Makowski, Matthew D. Smith, Jennifer M. Zupancic, Lina Wu, Yulei Zhang, John S. Schardt, Vani Santosh and P. N. Jayakumar and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and PLoS ONE.

In The Last Decade

Alec A. Desai

23 papers receiving 552 citations

Peers

Countries citing papers authored by Alec A. Desai

Since Specialization

Citations

This map shows the geographic impact of Alec A. Desai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alec A. Desai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alec A. Desai more than expected).

Fields of papers citing papers by Alec A. Desai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alec A. Desai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alec A. Desai. The network helps show where Alec A. Desai may publish in the future.

Co-authorship network of co-authors of Alec A. Desai

This figure shows the co-authorship network connecting the top 25 collaborators of Alec A. Desai. A scholar is included among the top collaborators of Alec A. Desai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alec A. Desai. Alec A. Desai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Facile generation of drug-like conformational antibodies specific for amyloid fibrils 2025 ·Nature Chemical Biology ·Alec A. Desai, Jennifer M. Zupancic, Hanna Trzeciakiewicz, Julia E. Gerson, (unknown), Mary E. Skinner, Lisa M. Sharkey, (unknown), Sean P. Ferris, Nemil Bhatt, Emily K. Makowski, Matthew D. Smith, Hongwei Chen, (unknown), (unknown), (unknown), Ravi S. Kane, Nicholas M. Kanaan, Henry L. Paulson, Peter M. Tessier	1
2	In Vivo Auto-tuning of Antibody–Drug Conjugate Delivery to Maximize Efficacy Using High-Avidity, Low-Affinity Antibodies 2025 ·Molecular Cancer Therapeutics ·(unknown), (unknown), (unknown), (unknown), Alec A. Desai, (unknown), (unknown), Jennifer J. Linderman, Peter M. Tessier, Greg M. Thurber	0
3	Maximizing activity and selectivity of antibody-mediated effector functions using antibody mixtures 2025 ·mAbs ·Tiexin Wang, Alec A. Desai, Greg M. Thurber, Peter M. Tessier	1
4	Human antibody polyreactivity is governed primarily by the heavy-chain complementarity-determining regions 2024 ·Cell Reports ·(unknown), Yulei Zhang, (unknown), (unknown), Matthew D. Smith, (unknown), Alec A. Desai, Emily K. Makowski, Giuseppe Licari, Yunxuan Xie, Michael S. Marlow, Sandeep Kumar, Peter M. Tessier	4
5	Facile generation of biepitopic antibodies with intrinsic agonism for activating tumor necrosis factor receptors 2024 ·Cell chemical biology ·(unknown), John S. Schardt, (unknown), (unknown), (unknown), (unknown), (unknown), Alec A. Desai, Peter M. Tessier	3
6	Rapid and Quantitative In Vitro Evaluation of SARS-CoV-2 Neutralizing Antibodies and Nanobodies 2022 ·Analytical Chemistry ·(unknown), Xiaotian Tan, Jennifer M. Zupancic, John S. Schardt, Alec A. Desai, Matthew D. Smith, Jie Zhang, Liangzhi Xie, (unknown), Peter M. Tessier, Xudong Fan	3
7	Co-optimization of therapeutic antibody affinity and specificity using machine learning models that generalize to novel mutational space 2022 ·Nature Communications ·Emily K. Makowski, (unknown), Jie Huang, Lina Wu, Matthew D. Smith, Tiexin Wang, Alec A. Desai, Craig Streu, Yulei Zhang, Jennifer M. Zupancic, John S. Schardt, Jennifer J. Linderman, Peter M. Tessier	91
8	Reduction of therapeutic antibody self-association using yeast-display selections and machine learning 2022 ·mAbs ·Emily K. Makowski, Hongwei Chen, Matthew Lambert, Eric M. Bennett, (unknown), Yulei Zhang, Jennifer M. Zupancic, Alec A. Desai, Matthew D. Smith, Wenjia Lou, Amendra Fernando, (unknown), (unknown), Laura Lin, Peter M. Tessier	18
9	Isolating Anti-amyloid Antibodies from Yeast-Displayed Libraries 2022 ·Methods in molecular biology ·Alec A. Desai, Jennifer M. Zupancic, Matthew D. Smith, Peter M. Tessier	4
10	A hybridoma-derived monoclonal antibody with high homology to the aberrant myeloma light chain 2021 ·PLoS ONE ·(unknown), (unknown), Alec A. Desai, (unknown), (unknown), Peter M. Tessier, Colin F. Greineder	5
11	Engineered Multivalent Nanobodies Potently and Broadly Neutralize SARS‐CoV‐2 Variants 2021 ·Advanced Therapeutics ·Jennifer M. Zupancic, John S. Schardt, Alec A. Desai, Emily K. Makowski, Matthew D. Smith, (unknown), Mayara Garcia de Mattos Barbosa, Marília Cascalho, Thomas M. Lanigan, Peter M. Tessier	30
12	Highly sensitive detection of antibody nonspecific interactions using flow cytometry 2021 ·mAbs ·Emily K. Makowski, Lina Wu, Alec A. Desai, Peter M. Tessier	26
13	Directed evolution of potent neutralizing nanobodies against SARS-CoV-2 using CDR-swapping mutagenesis 2021 ·Cell chemical biology ·Jennifer M. Zupancic, Alec A. Desai, John S. Schardt, (unknown), Emily K. Makowski, Matthew D. Smith, Andrew A. Kennedy, Mayara Garcia de Mattos Barbosa, Marília Cascalho, Thomas M. Lanigan, Andrew W. Tai, Peter M. Tessier	32
14	Discovery and characterization of high-affinity, potent SARS-CoV-2 neutralizing antibodies via single B cell screening 2021 ·Scientific Reports ·John S. Schardt, (unknown), Alec A. Desai, Kyong Soo Park, Jennifer M. Zupancic, Emily K. Makowski, Matthew D. Smith, Hongwei Chen, Mayara Garcia de Mattos Barbosa, Marília Cascalho, Thomas M. Lanigan, James J. Moon, Peter M. Tessier	16
15	Rational affinity maturation of anti-amyloid antibodies with high conformational and sequence specificity 2021 ·Journal of Biological Chemistry ·Alec A. Desai, Matthew D. Smith, Yulei Zhang, Emily K. Makowski, Julia E. Gerson, (unknown), Charles G. Starr, Jennifer M. Zupancic, Shannon J. Moore, Alexandra Sutter, Magdalena I. Ivanova, Geoffrey G. Murphy, Henry L. Paulson, Peter M. Tessier	16
16	Physicochemical Rules for Identifying Monoclonal Antibodies with Drug-like Specificity 2020 ·Molecular Pharmaceutics ·Yulei Zhang, Lina Wu, Priyanka Gupta, Alec A. Desai, Matthew D. Smith, Lilia A. Rabia, (unknown), Peter M. Tessier	38
17	Directed evolution of conformation‐specific antibodies for sensitive detection of polypeptide aggregates in therapeutic drug formulations 2020 ·Biotechnology and Bioengineering ·Wenjia Lou, (unknown), Alec A. Desai, Emily K. Makowski, (unknown), Jesper E. Mogensen, (unknown), (unknown), Arne Staby, Karen Duus, Jan Amstrup, Yulei Zhang, Peter M. Tessier	5
18	Sensitive detection of glucagon aggregation using amyloid fibril‐specific antibodies 2019 ·Biotechnology and Bioengineering ·(unknown), (unknown), Alec A. Desai, Jesper E. Mogensen, (unknown), (unknown), Arne Staby, Peter M. Tessier	8
19	Nature-inspired design and evolution of anti-amyloid antibodies 2019 ·Journal of Biological Chemistry ·(unknown), Lilia A. Rabia, Alec A. Desai, (unknown), Julia E. Gerson, Henry L. Paulson, Ravi S. Kane, Peter M. Tessier	22
20	Understanding and overcoming trade-offs between antibody affinity, specificity, stability and solubility 2018 ·Biochemical Engineering Journal ·Lilia A. Rabia, Alec A. Desai, (unknown), Peter M. Tessier	120

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact